Editor-in-Chief Robert M. Levy, M.D., Ph.D.
Neuromodulation: Technology at the Neural Interface is a peer-reviewed publication that was launched in 1998 as the journal of the International Neuromodulation Society (INS) and its regional chapters. Elsevier is the new publisher. The journal is currently published 8 times a year. We are also pleased to announce that Neuromodulation: Technology at the Neural Interface, has been indexed in MEDLINE by the National Library of Medicine.
The preeminent journal in the field of neuromodulation, Neuromodulation: Technology at the Neural Interface provides our readership state of the art clinical, translational and basic science research taking place around the wrold within our field and reflects the needs of the broad neuromodulation community. For clinicians, engineers, scientists, and members of the biotechnology industry alike, Neuromodulation: Technology at the Neural Interface provides timely and rigorously peer reviewed articles on the technology, science and clinical application of devices that interface with the nervous system to treat disease and improve function. Neuromodulation: Technology at the Neural Interface covers an ever expanding field including pain, headache, movement disorders, spasticity, paralysis, psychiatric disorders, epilepsy, sensory deprivation, gastric dysfunction, obesity and incontinence.
The journal represents the practice of a growing, diverse multidisciplinary field responsible for the development and application of devices and techniques to benefit patients by normalizing function and reducing suffering. In depth reviews, original articles, national and international meeting abstracts, special focus editions and web based educational offerings help the reader expand knowledge and understanding of the interface between electrical stimulation, chemical neuromodulation, the nervous system and the patient. Neurotechnology reports keep the reader informed of the rapidly changing landscape of the business of neuromodulation while our updates on past and future news of events and activities of the INS and its membership in the US and eslewhere keep the reader abreast of issues related to professional education and development.
Simply log in using the links at the top of this page or via the member login in the upper right and then follow the links to the journal.
Non-members can access these articles by joining the INS or NANS, or one of the other regional chapters.
Neuromodulation: Technology at the Neural Interface has been reviewed by the National Library of Medicine and accepted for indexing in MEDLINE / Index Medicus / PubMed. All content, from the journal's first issue through the present, is now Medline listed.
We invite manuscript submissions for publication in Neuromodulation. Please consult Neuromodulation's Author Guidelines for instructions. To submit a manuscript to Neuromodulation, click here.
Neuromodulation is published by Elsevier, as of January 1, 2022.
Authors can track the peer review process, and reviewers can access the manuscripts they've been assigned to review online - anytime. Full instructions and support for Editorial Manager are available, and a user ID and password can be obtained on the first visit.
Editorial Manager Support: https://www.elsevier.com/support
Please share this information with your colleagues and encourage them to submit their original work to Neuromodulation: Technology at the Neural Interface.
Neuromodulation: Technology at the Neural Interface Articles in Press are published on a regular basis online in advance of their appearance in a print issue. These articles are fully peer reviewed, edited, and complete – they only lack page numbers and volume/issue details – and are considered fully published from the date they first appear online. This online publication date is shown with the article.
The articles are available as full text HTML and can be cited as references by using their Digital Object Identifier (DOI) numbers. For more information on DOIs, please see http://www.doi.org/faq.html.
To view all the articles currently available online as Articles in Press, please visit the journal homepage. Prior to print publication, the Articles in Press online posting does not specify volume or issue number (which will appear online as "0" during this time between online and print publication). Upon print publication, the article volume and issue number will be shown and it will be listed in the relevant online issue, complete with page numbers and volume/issue details. No other changes will be made.
The implementation of Articles in Press for Neuromodulation represents our commitment to get manuscripts available to view to the academic community as quickly as possible, reducing time to publication considerably without sacrificing quality or completeness.
In addition to receiving traditional paper subscriptions, NANS Members, who are automatically International Neuromodulation Society (INS) members, can access their free online subscriptions simply by logging into the NANS members-only section and clicking on the link to the online journal. You may also use the links listed at the top of this page.
If you are having trouble accessing your online subscription, please email the Editorial Office and we will promptly assist you.
Robert M. Levy, M.D., Ph.D. Editor-in-Chief
Tia Sofatzis Managing Editor Tel: +1 415 683 3237 Fax: +1 415 683 3218
Mary Bockman Price Editorial Assistant
Follow the Neuromodulation Journal Social Media Accounts (@JNeuromod)
You may follow updates from Neuromodulation in its dedicated social media accounts on Facebook, Twitter and Instagram. Please like and follow those dedicated channels for timely notices of new journal content. The updates are also posted to the INS LinkedIn page.
Additionally, the INS has provided publicly guidance to members regarding participation as professionals in social media accounts, such as for the journal or the INS.
Journal page
If you have a membership profile with NANS, please make sure your information is accurate and up-to-date by logging into your account.
NANS 2024 Annual Meeting #PatientsFirst Caesar's Palace Las Vegas, NV